FDA Authorizes Myocene Device for Muscle Fatigue Monitoring and Informed Training Decisions
LIÈGE, Belgium, Jan. 27, 2025 (GLOBE NEWSWIRE) — Myocene, the Belgian sportstech company specializing in innovative muscle fatigue assessment for top-level athletes announced today that the US Food and Drug Administration (FDA) has granted authorization for its groundbreaking device, “intended to provide objective measures of muscle fatigue to inform athletic training decisions by coaches and […]